What does LOMEDICAL do?

LOMEDICAL is registered with the CBE as active in: Activiteiten van holdings. Private Limited, started on 15 April 2015, 1 establishment.

What is the address of LOMEDICAL?

The registered office of LOMEDICAL is located at Heikantstraat 23, 2900 Schoten.

Is LOMEDICAL still active?

Yes. According to the CBE (30 October 2026) LOMEDICAL is active, legal situation “Normale toestand”, started on 15 April 2015.

Is LOMEDICAL registered on Peppol?

Yes, LOMEDICAL is registered on the Peppol network with ID 0208:0628750931.

What is the enterprise number of LOMEDICAL?

The enterprise number of LOMEDICAL is BE0628750931.

When was LOMEDICAL founded?

LOMEDICAL was founded on 15 April 2015.

Who are the directors of LOMEDICAL?

According to the 2025 annual accounts, the directors of LOMEDICAL are: Julie Lombart.

Is LOMEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 April 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LOMEDICAL make in 2025?

LOMEDICAL posted a profit after taxes of € 87,947 in financial year 2025.

What is the revenue of LOMEDICAL?

As a small company, LOMEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 49,517.

LOMEDICAL (Private Limited) - Schoten - BE0628750931

Dossier LOMEDICAL, printed on 30 October 2026 from databakkes.be/en/0628750931/lomedical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LOMEDICAL from Schoten, company number BE0628750931, closed financial year 2025 with a result of € 87,947 after tax. For that financial year LOMEDICAL recorded a gross margin of € 49,517 and equity of € 433,946. Compared with financial year 2024, the result moved from € 47,674 to € 87,947. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 433,946

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 87,947

▲ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 32,439

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 21,973 paid out

25 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,267

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 168,628

▼ 19% vs 2024

€ 36,989 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Taxes

€ 2,376

▼ 68% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 65,105 Gross margin 2022: € 65,105 First fiscal year in the series	€ 60,530 Gross margin 2023: € 60,530 ▼ 7% vs 2022 (€ 65,105) Unfavourable step	€ 68,391 Gross margin 2024: € 68,391 ▲ 13% vs 2023 (€ 60,530) Favourable step	€ 49,517 Gross margin 2025: € 49,517 ▼ 28% vs 2024 (€ 68,391) Unfavourable step	▼ 28%
Profit after taxes	€ 55,860 Profit after taxes 2022: € 55,860 First fiscal year in the series	€ 65,303 Profit after taxes 2023: € 65,303 ▲ 17% vs 2022 (€ 55,860) Favourable step	€ 47,674 Profit after taxes 2024: € 47,674 ▼ 27% vs 2023 (€ 65,303) Unfavourable step	€ 87,947 Profit after taxes 2025: € 87,947 ▲ 84% vs 2024 (€ 47,674) Favourable step	▲ 84%
Equity	€ 254,995 Equity 2022: € 254,995 First fiscal year in the series	€ 320,299 Equity 2023: € 320,299 ▲ 26% vs 2022 (€ 254,995) Favourable step	€ 367,973 Equity 2024: € 367,973 ▲ 15% vs 2023 (€ 320,299) Favourable step	€ 433,946 Equity 2025: € 433,946 ▲ 18% vs 2024 (€ 367,973) Favourable step	▲ 18%
Total debts	€ 375,823 Total debts 2022: € 375,823 First fiscal year in the series	€ 302,742 Total debts 2023: € 302,742 ▼ 19% vs 2022 (€ 375,823) Favourable step	€ 262,770 Total debts 2024: € 262,770 ▼ 13% vs 2023 (€ 302,742) Favourable step	€ 216,802 Total debts 2025: € 216,802 ▼ 17% vs 2024 (€ 262,770) Favourable step	▼ 17%
Cash	€ 20,368 Cash 2022: € 20,368 First fiscal year in the series	€ 22,408 Cash 2023: € 22,408 ▲ 10% vs 2022 (€ 20,368) Favourable step	€ 32,927 Cash 2024: € 32,927 ▲ 47% vs 2023 (€ 22,408) Favourable step	€ 32,439 Cash 2025: € 32,439 ▼ 1% vs 2024 (€ 32,927) Unfavourable step	▼ 1%
Retained profit	€ 236,445 Retained profit 2022: € 236,445 First fiscal year in the series	€ 301,749 Retained profit 2023: € 301,749 ▲ 28% vs 2022 (€ 236,445) Favourable step	€ 349,423 Retained profit 2024: € 349,423 ▲ 16% vs 2023 (€ 301,749) Favourable step	€ 415,396 Retained profit 2025: € 415,396 ▲ 19% vs 2024 (€ 349,423) Favourable step	▲ 19%
Dividend	€ 25,887 Dividend 2022: € 25,887 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 25,887) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 21,973 Dividend 2025: € 21,973 Unchanged (€ 0) Unchanged
Bank debt	€ 288,215 Bank debt 2022: € 288,215 First fiscal year in the series	€ 247,982 Bank debt 2023: € 247,982 ▼ 14% vs 2022 (€ 288,215) Favourable step	€ 207,140 Bank debt 2024: € 207,140 ▼ 16% vs 2023 (€ 247,982) Favourable step	€ 168,628 Bank debt 2025: € 168,628 ▼ 19% vs 2024 (€ 207,140) Favourable step	▼ 19%
Balance sheet total	€ 630,818 Balance sheet total 2022: € 630,818 First fiscal year in the series	€ 623,041 Balance sheet total 2023: € 623,041 ▼ 1% vs 2022 (€ 630,818) Unchanged	€ 630,743 Balance sheet total 2024: € 630,743 ▲ 1% vs 2023 (€ 623,041) Unchanged	€ 650,748 Balance sheet total 2025: € 650,748 ▲ 3% vs 2024 (€ 630,743) Unchanged	▲ 3%

Key figures of LOMEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LOMEDICAL?

What happened at LOMEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 87,947 (▲ 84% vs 2024). Source: NBB ↗
Apr 15, 2015 New establishment in Antwerpen. KBO
2015 Julie Lombart became a director. NBB
Apr 15, 2015 Start of the company according to the CBE. KBO

In short

From € 55,860 profit in 2022 to € 87,947 profit in 2025.

Paid € 65,347 in corporate taxes since 2022.

Best year ever: 2025, with € 87,947 profit.

Paid out € 47,860 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Julie Lombart

LOMEDICAL

Apotheek Arena 50%

Behind LOMEDICAL is Julie Lombart. It owns 50% of Apotheek Arena itself.

Directors

According to the 2025 annual accounts

Julie Lombart

Bestuurder

Also active at: APOTHEEK ARENA

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Heikantstraat 23

2900 Schoten

2.241.542.118

Lange Leemstraat 54

2018 Antwerpen

Active since 15 April 2015

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0628.750.931

VAT number

BE 0628.750.931

Registered office

Heikantstraat 23, 2900 Schoten

Names & denominations

LOMEDICAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

15 April 2015

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van holdings

Holdings

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

LOMEDICAL

Financials

What happened to LOMEDICAL?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions